Breast Cancer Clinical Trial

The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures

Summary

To determine if a virtual reality simulation will reduce pain and anxiety in patients undergoing an ultrasound guided breast biopsy procedure.

View Full Description

Full Description

Breast biopsies for patients with abnormal mammograms are required to identify cancerous tissue. Currently this procedure is done with or without a local anesthetic. Patients report anxiety regarding potentially having cancer and the possibility of cancer-related procedures. Different types of biopsies may have different pain and anxiety based on their duration and complexity. This research is designed to determine if VR simulated environment can reduce pain and anxiety.

The aim is to study the efficacy of a virtual environment in reducing pain and procedural anxiety. It is intended for patients undergoing an ultrasound guided breast biopsy procedure that have had an abnormal mammogram. The overall aim is to discover an efficacious nonpharmacologic method to lower pain and anxiety during a standard of care procedure.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Informed consent is obtained from the patient
Females who are 18 years of age
Patient is scheduled for preoperative ultrasound guided breast biopsy procedure

Exclusion Criteria:

Patient is scheduled for a stereotactic biopsy procedure
The patient has motion sickness
The patient has severe cognitive disabilities or language barriers that inhibit study form completion in English
The patient has a history of seizures or epilepsy
Refusal of patient to sign consent

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT05042999

Recruitment Status:

Enrolling by invitation

Sponsor:

Prisma Health-Upstate

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Patewood Outpatient Surgery Center
Greenville South Carolina, 29615, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT05042999

Recruitment Status:

Enrolling by invitation

Sponsor:


Prisma Health-Upstate

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.